Form 4: Medline CEO Receives Stock Grant
Insider Transaction (Form 4)
James M Boyle, Chief Executive Officer and a Director of Medline Inc., received 764,252 shares of common stock on August 19, 2026.
Summary
- Grant/award: acquired 764,252 Incentive Units of Medline Holdings, LP on August 19, 2026; holds 764,252 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
James M Boyle — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Grant/award | Incentive Units of Medline Holdings, LP | 764,252 | — | — | 764,252 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Grant/award (764,252 shares) |
Keywords
insider transaction, Form 4, MDLN, Medline Inc., neutral, James M Boyle
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.